• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     NIHR Health Services and Delivery Research programme Integration and continuity of primary care: polyclinics and alternatives - a patient-centred analysis of how organisation constrains care co-ordination
2015     Haute Autorite de sante (HAS) [Measurement of nitric oxide (NO) in exhaled air]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab (Avastin®) in combination with chemotherapy as second-line therapy for HER2-negative, locally recurrent or metastatic breast cancer that has progressed after first-line treatment with bevacizumab plus chemotherapy
2015     National Institute for Health and Care Excellence (NICE) Repetitive transcranial magnetic stimulation for depression. NICE interventional procedures guidance 542
2015     NIHR Health Technology Assessment programme Systematic review of tools to measure outcomes for young children with autism spectrum disorder
2015     NIHR Health Services and Delivery Research programme Research utilisation and knowledge mobilisation in the commissioning and joint planning of public health interventions to reduce alcohol-related harms: a qualitative case design using a cocreation approach
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses]
2015     National Institute for Health and Care Excellence (NICE) Joint distraction for ankle osteoarthritis. NICE interventional procedures guidance 538
2015     Haute Autorite de sante (HAS) [Rare visceral surgery procedures by laparoscopy]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Nivolumab BMS®) for the second-line therapy of metastatic squamous non-small cell lung cancer
2015     National Institute for Health and Care Excellence (NICE) Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma. NICE interventional procedures guidance 539
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ramucirumab in combination with paclitaxel as second-line treatment for adult patients with advanced gastric or gastro-oesophageal junction carcinoma
2015     Norwegian Institute of Public Health (NIPH) [Autologous hematopoietic stemcell transplantation (HSCT) for multiple sclerosis]
2015     National Institute for Health and Care Excellence (NICE) Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease. NICE interventional procedures guidance 540
2015     NIHR Health Technology Assessment programme A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
2015     NIHR Health Technology Assessment programme A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)
2015     NIHR Health Services and Delivery Research programme Family-Reported Experiences Evaluation (FREE) study: a mixed-methods study to evaluate families' satisfaction with adult critical care services in the NHS
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carfilzomib (Kyprolis®) for patients with relapsed multiple myeloma who have received one to three prior lines of therapy
2015     National Institute for Health and Care Excellence (NICE) Insertion of a subretinal prosthesis system for retinitis pigmentosa. NICE interventional procedures guidance 537
2015     NIHR Health Services and Delivery Research programme Delivering patient choice in clinical practice: a conversation analytic study of communication practices used in neurology clinics to involve patients in decision-making
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015     Health Information and Quality Authority (HIQA) Health technology assessment of a selective BCG vaccination programme
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review]
2015     National Institute for Health and Care Excellence (NICE) Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes. NICE interventional procedures guidance 534
2015     NIHR Health Services and Delivery Research programme Multisite implementation of trained volunteer doula support for disadvantaged childbearing women: a mixed-methods evaluation
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost studies of type 2 diabetes: a review of literature]
2015     Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment]
2015     Norwegian Institute of Public Health (NIPH) A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients
2015     National Institute for Health and Care Excellence (NICE) Living-donor liver transplantation. NICE interventional procedures guidance 535
2015     Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015     Agency for Healthcare Research and Quality (AHRQ) Catheter ablation for treatment of atrial fibrillation
2015     Health Information and Quality Authority (HIQA) Health technology assessment of the use of information technology for early warning and clinical handover systems
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment]
2015     National Institute for Health and Care Excellence (NICE) Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. NICE interventional procedures guidance 536
2015     Health Quality Ontario (HQO) Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015     NIHR Health Services and Delivery Research programme A systematic review and metaethnography to identify how effective, cost-effective, accessible and acceptable self-management support interventions are for men with long-term conditions (SELF-MAN)
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) for the treatment of advanced melanoma
2015     Norwegian Institute of Public Health (NIPH) [Alternatives of plasma for transfusion to patients]
2015     National Institute for Health and Care Excellence (NICE) Implanting a baroreceptor stimulation device for resistant hypertension. NICE interventional procedures guidance 533
2015     Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015     NIHR Health Services and Delivery Research programme Integration and continuity of primary care: polyclinics and alternatives - a patient-centred analysis of how organisation constrains care co-ordination
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Robot-assisted surgery: a systematic review of effectiveness and safety for elected indications and accumulating costs]
2015     Norwegian Institute of Public Health (NIPH) Cost-effectiveness of HPV-vaccination of boys aged 12 in a Norwegian setting
2015     National Institute for Health and Care Excellence (NICE) Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer. NICE interventional procedures guidance 532
2015     NIHR Health Services and Delivery Research programme The Birthplace in England national prospective cohort study: further analyses to enhance policy and service delivery decision-making for planned place of birth
2015     Agency for Healthcare Research and Quality (AHRQ) Diagnosis of right lower quadrant pain and suspected acute appendicitis
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [The effects of tangible and intangible incentives on health behaviour]
2015     National Institute for Health and Care Excellence (NICE) Preoperative high dose rate brachytherapy for rectal cancer. NICE interventional procedures guidance 531
2015     Blue Cross Blue Shield Association (BCBS) Special report: early intensive behavioral intervention and other behavioral interventions for autism spectrum disorder
2015     NIHR Health Services and Delivery Research programme Establishing and implementing best practice to reduce unplanned admissions in those aged 85 years and over through system change [Establishing System Change for Admissions of People 85+ (ESCAPE 85+)]: a mixed-methods case study approach
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Raltegravir (Isentress®)
2015     National Institute for Health and Care Excellence (NICE) Transcranial direct current stimulation (tDCS) for depression. NICE interventional procedures guidance 530
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eculizumab (Soliris®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sucroferric oxyhydroxide (Velphoro®)
2015     National Institute for Health and Care Excellence (NICE) Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section. NICE interventional procedures guidance 528
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ledipasvir/sofosbuvir (Harvoni®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tinzaparin sodium (Innohep®)
2015     National Institute for Health and Care Excellence (NICE) Joint distraction for knee osteoarthritis without alignment correction. NICE interventional procedures guidance 529
2015     National Institute for Health and Care Excellence (NICE) Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C. NICE medical technologies guidance 27
2015     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]
2015     University of York Supporting self-management: helping people manage long-term conditions
2015     NIHR Health Technology Assessment programme The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Denosumab (Xgeva®)
2015     National Institute for Health and Care Excellence (NICE) Suture fixation of acute disruption of the distal tibiofibular syndesmosis. NICE interventional procedures guidance 521
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tedizolid phosphate (Sivextro®)
2015     National Institute for Health and Care Excellence (NICE) Ultrasound-enhanced, catheter-directed thrombolysis for deep vein thrombosis. NICE interventional procedures guidance 523
2015     University of York Promoting patient-centred care planning consultations
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin glargine (Abasaglar®)
2015     National Institute for Health and Care Excellence (NICE) Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism. NICE interventional procedures guidance 524
2015     National Institute for Health and Care Excellence (NICE) Tegaderm CHG securement dressing for vascular access sites in critically ill adults. NICE medical technologies guidance 25
2015     NIHR Health Technology Assessment programme Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study
2015     University of York Evidence to inform the commissioning of social prescribing
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin degludec/liraglutide (Xultophy®)
2015     Health Information and Quality Authority (HIQA) Health technology assessment of chronic disease self-management support interventions
2015     National Institute for Health and Care Excellence (NICE) Electrotherapy for the treatment of haemorrhoids. NICE interventional procedures guidance 525
2015     NIHR Health Technology Assessment programme Elosulfase alfa for treating mucopolysaccharidosis type IVA [ID744]
2015     National Institute for Health and Care Excellence (NICE) Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache. NICE interventional procedures guidance 527
2015     University of York Recognising and managing frailty in primary care
2015     NIHR Health Technology Assessment programme Secukinumab for treating moderate to severe plaque psoriasis
2015     National Institute for Health and Care Excellence (NICE) Insertion of an epiretinal prosthesis for retinitis pigmentosa. NICE interventional procedures guidance 519
2015     University of York Triage and minimising crowding in emergency departments
2015     National Institute for Health and Care Excellence (NICE) Radiofrequency ablation for gastric antral vascular ectasia. NICE interventional procedures guidance 520
2015     National Institute for Health and Care Excellence (NICE) The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters. NICE medical technologies guidance 24
2015     National Institute for Health and Care Excellence (NICE) Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section. NICE interventional procedures guidance 515
2015     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn's disease: a systematic review and meta-analysis
2015     Norwegian Knowledge Centre for the Health Services (NOKC) [First aid training may improve first aid skills]
2015     National Institute for Health and Care Excellence (NICE) Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation. NICE interventional procedures guidance 516
2015     Health Quality Ontario (HQO) Capsule endoscopy in the assessment of obscure gastrointestinal bleeding: an evidence-based analysis
2015     Norwegian Knowledge Centre for the Health Services (NOKC) A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients
2015     National Institute for Health and Care Excellence (NICE) Insertion of endobronchial nitinol coils to improve lung function in emphysema. NICE interventional procedures guidance 517
2015     Health Quality Ontario (HQO) Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: An Economic Analysis
2015     NIHR Health Services and Delivery Research programme What is the evidence for the effectiveness, appropriateness and feasibility of group clinics for patients with chronic conditions?
2015     National Institute for Health and Care Excellence (NICE) Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes. NICE interventional procedures guidance 518
2015     NIHR Health Technology Assessment programme Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders
2015     Health Quality Ontario (HQO) Is Transient Ischemic Attack a Medical Emergency? An Evidence-Based Analysis
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Detection and diagnosis of Alzheimer's disease and other neurocognitive disorders]
2015     National Institute for Health and Care Excellence (NICE) Flexible endoscopic treatment of a pharyngeal pouch. NICE interventional procedures guidance 513
2015     Health Quality Ontario (HQO) Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis
2015     NIHR Health Technology Assessment programme The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation